Authors: Souček P. Boguzsaková J. Cihelková I. Authors‘ workplace: Oční klinika FNKV, Praha, přednosta prof. MUDr. P. Kuchynka, CSc. Katedra oftalmologie IPVZ, Praha, vedoucí prof. MUDr. J. Boguszaková, DrSc. Published in: Čes. a slov. Oftal., , 2002, No. 2, p. 89-97 Category:
Photodynamic therapy with the preparation Visudyne (PDT) is the only treatmentwhich retards statistically significantly the decline of vision in patients with agerelated and myopic macular degeneration with a subfoveal, predominantly classicchoroidal neovascularization. The authors present their own experience with thetreatment of the first 12 patients. During 6-month treatment a loss of more than3 lines of ETDRS optotypes was recorded in two patients (17%). The presentedresults of FTV are consistent with data published abroad. As the one-year therapeutic results in two patients are encouraging, it will be necessary in future toprolong the follow up time and increase the number of patients.
Key words: digital imaging system, photodynamic therapy, choroidal neovascu-larization, myopia, verteporfin, age-related macular degeneration, VisudyneTM
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
